Aligos Therapeutics, Inc. announced it raised $85 Million in an initial filing from an offering of $125 Million

Jan 16, 2020•over 5 years ago

Amount Raised

$85 Million

San FranciscoBiotechnology

Company Information

Company

Aligos Therapeutics

Location

One Corporate Dr., 2nd Floor

San Francisco, California, United States

About

Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Aligos Therapeutics, Inc. announced it raised $85 Million in an initial filing from an offering of $125 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information